Señales en vivo de HTGM | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (14 jun 2023 @ 16:00):

Stats
Volumen de hoy	725 429
Volumen promedio	253 915
Capitalización de mercado	1.06M
EPS	$0 ( 2024-03-28 )
Próxima fecha de ganancias	( $0 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0281
ATR14	$0.314 (65.42%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-08	Barat Stephen	Sell	888	Common Stock
2023-03-31	Barat Stephen	Sell	52	Common Stock
2023-02-02	Barat Stephen	Sell	0	Common Stock
2023-02-02	Barat Stephen	Sell	4 166	Stock Option (right to buy)
2023-02-02	Barat Stephen	Sell	2 083	Stock Option (right to buy)

INSIDER POWER
93.68
Last 98 transactions
Buy: 3 245 171 \| Sell: 16 674

Volumen Correlación

Largo: 0.10 (neutral)

Corto: -0.53 (weak negative)

Signal:(18.674) Neutral

HTG Molecular Diagnostics Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

HTG Molecular Diagnostics Correlación - Moneda/Commodity

0.12
( neutral )

-0.68
( moderate negative )

-0.28
( neutral )

-0.15
( neutral )

0.03
( neutral )

-0.25
( neutral )

HTG Molecular Diagnostics Finanzas

Annual	2022
Ingresos:	$6.37M
Beneficio Bruto:	$1.79M (28.18 %)
EPS:	$-24.28

FY	2022
Ingresos:	$6.37M
Beneficio Bruto:	$1.79M (28.18 %)
EPS:	$-24.28

FY	2021
Ingresos:	$8.91M
Beneficio Bruto:	$716 868 (8.05 %)
EPS:	$-0.206

FY	2020
Ingresos:	$8.55M
Beneficio Bruto:	$4.56M (53.31 %)
EPS:	$-0.376

Financial Reports:

No articles found.

HTG Molecular Diagnostics

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.